Cellebrite DI (CLBT) Competitors

Dynatrace (NYSE:DT) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Which has more volatility and risk, DT or CLBT?

Dynatrace has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500.

Does the media favor DT or CLBT?

In the previous week, Dynatrace had 2 more articles in the media than Cellebrite DI. MarketBeat recorded 21 mentions for Dynatrace and 19 mentions for Cellebrite DI. Dynatrace's average media sentiment score of 1.07 beat Cellebrite DI's score of 0.79 indicating that Dynatrace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dynatrace	11 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Cellebrite DI	9 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Is DT or CLBT more profitable?

Dynatrace has a net margin of 27.75% compared to Cellebrite DI's net margin of -34.56%. Cellebrite DI's return on equity of 23.92% beat Dynatrace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatrace	27.75%	9.15%	6.00%
Cellebrite DI	-34.56%	23.92%	11.94%

Do insiders & institutionals have more ownership in DT or CLBT?

94.3% of Dynatrace shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 0.6% of Dynatrace shares are held by company insiders. Comparatively, 5.7% of Cellebrite DI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Do analysts recommend DT or CLBT?

Dynatrace presently has a consensus target price of $62.63, indicating a potential upside of 26.75%. Cellebrite DI has a consensus target price of $22.40, indicating a potential upside of 39.04%. Given Cellebrite DI's stronger consensus rating and higher possible upside, analysts clearly believe Cellebrite DI is more favorable than Dynatrace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatrace	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.78
Cellebrite DI	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher earnings & valuation, DT or CLBT?

Dynatrace has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than Dynatrace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatrace	$1.70B	8.77	$483.68M	$1.63	30.31
Cellebrite DI	$401.20M	9.62	-$283.01M	-$0.76	-21.20

Summary

Dynatrace beats Cellebrite DI on 10 of the 17 factors compared between the two stocks.